Results 41 to 50 of about 237 (135)
Abstract Book: 25th Congress of the European Hematology Association Virtual Edition, 2020
HemaSphere, Volume 4, Issue S1, Page 1-1168, June 2020.
wiley +1 more source
PREVENCIJA I LIJEČENJE RAKA DOJKE KOD ŽENA
Čovjek je nekim bolestima doživotno obilježen. Na tijelu i duši ostaju ožiljci. Rak dojke ne ostavlja samo vanjske vidljive tragove na ženskom tijelu.
Fabekovec, Martina
core
Therapy decision-making in prostate cancer has traditionally been limited to clinical, histopathological, and radiological variables that does not take into account the varying biology of prostate cancer manifestations.
Hrkač, Adelina +29 more
core +1 more source
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley +1 more source
Análise da influência da morfologia porosa de implantes de titânio no processo de crescimento ósseo [PDF]
Tese (doutorado) - Universidade Federal de Santa Catarina, Centro Tecnológico, Programa de Pós-graduação em Ciências e Engenharia de Materiais, Florianópolis, 2013.O tecido ósseo está sempre suscetível a lesões, causadas por agentes externos ou ...
Moreira, Anderson Camargo
core
Kvaliteta života kod onkoloških bolesnika
U Hrvatskoj je rak važan zdravstveni problem i nalazi se na drugom mjestu ljestvice uzroka smrti, odmah nakon bolesti kardiovaskularnog sustava. Svaka peta osoba u Hrvatskoj je umrla zbog obolijevanja od maligne bolesti. Način proživljavanja bolesti raka
Ljubas, Matea
core
The aim of the article is to demonstarte the relationship of the witch-doctor, a Podlasie healer, with nature. It presents a lexicographical analysis of the word szeptucha, centred primarily around Jan Karłowicz’s definition proposed in the dictionary of
Kuzyka, Julia
core +1 more source
Medularni rak ščitnice (ang. Medullary Thyroid Cancer, MTC) predstavlja okoli 3,5 % vseh rakov ščitnice in se uvršča med redke bolezni. MTC je nevroendokrini tumor, ki v nasprotju z ostalimi vrstami raka ščitnice ne izhaja iz folikularnih celic ščitnice,
Krošelj, Marko
core

